BUSINESSMEDPAGE TODAY
Alibaba to Pay $600M Over Allegations of Illegal Pharmaceutical Sales in the U.S.
Alibaba will pay $600 million to the U.S. government to resolve allegations of selling and importing illegal pharmaceuticals, controlled substances, and regulated chemicals. The dispute involves claims that the Hangzhou-based tech firm engaged in unauthorized pharmaceutical sales in the U.S.
Mentioned
Related Signal
Adjacent reporting
- Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
- Alibaba to pay US $600M to settle allegations it allowed illegal drug and equipment sales
- Alibaba agrees to pay $600 million to settle DOJ probe into illegal drug sales
- Alibaba to pay $600m to settle illegal drug sales allegations in US probe